Harmony Biosciences Holdings, Inc. HRMY Payment Of Upfront Fee Investing Activities
Payment Of Upfront Fee Investing Activities at other companies
Other financials
Where this comes from
Reported directly by Harmony Biosciences Holdings, Inc. in its filing.
Tagged under the XBRL concept hrmy:PaymentOfUpfrontFeeInvestingActivities.
The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Harmony Biosciences Holdings, Inc.'s payment of upfront fee investing activities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Harmony Biosciences Holdings, Inc.'s payment of upfront fee investing activities?
- Harmony Biosciences Holdings, Inc. (HRMY) reported payment of upfront fee investing activities of $32M in Q1 2026.
- How has Harmony Biosciences Holdings, Inc.'s payment of upfront fee investing activities changed year-over-year?
- Harmony Biosciences Holdings, Inc.'s payment of upfront fee investing activities increased by 753.3% year-over-year, from $3.75M to $32M.
- What does payment of upfront fee investing activities mean?
- This represents initial cash payments made to acquire rights, licenses, or assets from third parties, often at the inception of a strategic partnership or acquisition. It reflects the upfront capital commitment required to secure future growth opportunities or intellectual property. Investors analyze this to evaluate the cost of business development and the company's strategy for expanding its product portfolio.